Literature DB >> 17242867

Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever.

Ismail Sari1, Oguzhan Karaoglu, Gercek Can, Servet Akar, Aytac Gulcu, Merih Birlik, Nurullah Akkoc, Mehmet Tunca, Yigit Goktay, Fatos Onen.   

Abstract

Systemic inflammation plays an important role in the development of atherosclerosis (AS). The aim of this study was to evaluate the presence of early AS in patients with familial Mediterranean fever (FMF) that is characterized by recurrent inflammatory attacks of serositis. Sixty-one FMF patients (30 Male/31 Female; 31.5 [18-54] years) and 31 healthy controls (16 Male/15 Female; 31 [22-58] years) were studied. All FMF patients were on regular daily colchicine treatment and during attack-free periods. Both the FMF patients and controls with a history of diabetes mellitus (DM), hypertension, and hyperlipidemia were excluded. Body mass index (BMI) was calculated. Serum lipids, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR) were assessed. Two-hour oral glucose tolerance test was performed to rule out DM and glucose intolerance. To investigate early AS "endothelium-dependent flow-mediated dilatation (FMD%)," "nitroglycerin-induced endothelium-independent peripheral vasodilatation (NTG%)," and intima-media thickness (IMT) of common carotid arteries (CCA) were measured by ultrasonograpy. The median disease duration for FMF patients was 16 (1-45) years. Age, sex, BMI, smoking status, and serum lipids were comparable in patients and controls (p > 0.05). However, ESR and standard CRP were significantly higher in the patients group (p < 0.05). There were no differences in the measurements of right, left, and averaged IMT of CCA between patients and controls ([0.49 vs 0.5], [0.51 vs 0.52] and [0.5 vs 0.51]; p > 0.05, respectively). None of the subjects had carotid artery plaques. FMD% and NTG% were also similar in patients and controls group ([18.2 vs 20.6] and [24.2 vs 22.5]; p > 0.05, respectively). This study suggests that the markers of early AS are not impaired in FMF patients on regular daily colchicine treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17242867     DOI: 10.1007/s10067-006-0529-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  33 in total

Review 1.  Endothelial cell activation, injury, damage and dysfunction: separate entities or mutual terms?

Authors:  A D Blann
Journal:  Blood Coagul Fibrinolysis       Date:  2000-10       Impact factor: 1.276

Review 2.  Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis.

Authors:  Naveed Sattar; David W McCarey; Hilary Capell; Iain B McInnes
Journal:  Circulation       Date:  2003-12-16       Impact factor: 29.690

Review 3.  Accelerated atherosclerosis in autoimmune rheumatic diseases.

Authors:  Yehuda Shoenfeld; Roberto Gerli; Andrea Doria; Eiji Matsuura; Marco Matucci Cerinic; Nicoletta Ronda; Luis J Jara; Mahmud Abu-Shakra; Pier Luigi Meroni; Yaniv Sherer
Journal:  Circulation       Date:  2005-11-22       Impact factor: 29.690

4.  Impaired endothelial function in patients with ankylosing spondylitis.

Authors:  I Sari; T Okan; S Akar; H Cece; C Altay; M Secil; M Birlik; F Onen; N Akkoc
Journal:  Rheumatology (Oxford)       Date:  2005-10-04       Impact factor: 7.580

5.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.

Authors: 
Journal:  Diabetes Care       Date:  1997-07       Impact factor: 19.112

6.  Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses.

Authors:  J Danesh; P Whincup; M Walker; L Lennon; A Thomson; P Appleby; J R Gallimore; M B Pepys
Journal:  BMJ       Date:  2000-07-22

7.  Possible effect of subclinical inflammation on daily life in familial Mediterranean fever.

Authors:  Z Birsin Ozçakar; Fatoş Yalçinkaya; Selçuk Yüksel; Banu Acar; Derya Gökmen; Mesiha Ekim
Journal:  Clin Rheumatol       Date:  2005-09-20       Impact factor: 2.980

8.  Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.

Authors:  Mary J Roman; Beth-Ann Shanker; Adrienne Davis; Michael D Lockshin; Lisa Sammaritano; Ronit Simantov; Mary K Crow; Joseph E Schwartz; Stephen A Paget; Richard B Devereux; Jane E Salmon
Journal:  N Engl J Med       Date:  2003-12-18       Impact factor: 91.245

9.  Screening for atherosclerosis in patients with rheumatoid arthritis: comparison of two in vivo tests of vascular function.

Authors:  S Van Doornum; G McColl; A Jenkins; D J Green; I P Wicks
Journal:  Arthritis Rheum       Date:  2003-01

10.  Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations.

Authors:  H J Lachmann; B Sengül; T U Yavuzşen; D R Booth; S E Booth; A Bybee; J R Gallimore; M Soytürk; S Akar; M Tunca; P N Hawkins
Journal:  Rheumatology (Oxford)       Date:  2006-01-10       Impact factor: 7.580

View more
  30 in total

1.  Normal QT dispersion in colchicine-resistant familial Mediterranean fever (FMF).

Authors:  Udi Nussinovitch; Avi Livneh; Benjamin Volovitz; Moshe Nussinovitch; Ilan Ben-Zvi; Merav Lidar; Naomi Nussinovitch
Journal:  Clin Rheumatol       Date:  2012-04-18       Impact factor: 2.980

2.  QT interval variability in familial Mediterranean fever: a study in colchicine-responsive and colchicine-resistant patients.

Authors:  Udi Nussinovitch; Keren Kaminer; Moshe Nussinovitch; Benjamin Volovitz; Merav Lidar; Naomi Nussinovitch; Avi Livneh
Journal:  Clin Rheumatol       Date:  2012-01-25       Impact factor: 2.980

3.  Evaluation of endothelial dysfunction in patients with familial Mediterranean fever: the relationship between the levels of asymmetric dimethylarginine and endocan with carotid intima-media thickness and endothelium-dependent vasodilation.

Authors:  Veysel Ozalper; Muammer Kara; Alpaslan Tanoglu; Ibrahim Cetındaglı; Coskun Ozturker; Yusuf Hancerlı; Serdar Hıra; Kemal Kara; Yavuz Beyazıt; Yusuf Yazgan
Journal:  Clin Rheumatol       Date:  2017-01-10       Impact factor: 2.980

4.  P-wave dispersion in systemic AA amyloidosis of familial Mediterranean fever.

Authors:  Udi Nussinovitch; Avi Livneh; Moshe Nussinovitch; Benjamin Volovitz; Ilan Ben-Zvi; Merav Lidar; Naomi Nussinovitch
Journal:  Clin Rheumatol       Date:  2011-04-12       Impact factor: 2.980

5.  QT dispersion in uncomplicated familial Mediterranean fever.

Authors:  Naomi Nussinovitch; Avi Livneh; Keren Katz; Pnina Langevitz; Olga Feld; Moshe Nussinovitch; Benjamin Volovitz; Merav Lidar; Udi Nussinovitch
Journal:  Clin Rheumatol       Date:  2010-04-11       Impact factor: 2.980

Review 6.  Non-canonical manifestations of familial Mediterranean fever: a changing paradigm.

Authors:  Donato Rigante; Giuseppe Lopalco; Giusyda Tarantino; Adele Compagnone; Michele Fastiggi; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2015-03-13       Impact factor: 2.980

7.  Familial mediterranean Fever as an emerging clinical model of atherogenesis associated with low-grade inflammation.

Authors:  Sahru Yüksel; Lilit Ayvazyan; Armen Yuri Gasparyan
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

8.  Mean platelet volume in children with familial Mediterranean fever.

Authors:  Balahan Makay; Zeynep Türkyilmaz; Erbil Unsal
Journal:  Clin Rheumatol       Date:  2009-03-13       Impact factor: 2.980

9.  Heart rate variability in familial Mediterranean fever.

Authors:  Naomi Nussinovitch; Avi Livneh; Keren Katz; Pnina Langevitz; Olga Feld; Moshe Nussinovitch; Benjamin Volovitz; Merav Lidar; Udi Nussinovitch
Journal:  Rheumatol Int       Date:  2009-11-01       Impact factor: 2.631

10.  Evaluation of circulating endothelial biomarkers in familial Mediterranean fever.

Authors:  Baris Onder Pamuk; Ismail Sari; Sema Selcuk; Goksel Gokce; Didem Leyla Kozaci
Journal:  Rheumatol Int       Date:  2013-01-29       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.